We deliver in-depth GxP gap analyses across critical regulatory and quality domains — ensuring alignment with MHRA, EMA, and EudraLex GMP expectations.
Our assessments cover:
Pharmacovigilance (PV): PSMF, SDEAs, signal management, and reporting systems
Good Manufacturing Practice (GMP): Annex-specific compliance reviews and documentation
Good Distribution Practice (GDP): WDA licensing, transport, and supply chain oversight
Regulatory Affairs (RA): CTA and MAA dossier structure, eCTD operations, and submission readiness
Medical Devices & IVDs: MDR/IVDR technical file evaluation and conformity documentation
Each assessment is benchmarked against current regulatory baselines, resulting in clear, risk-based remediation plans with defined priorities, timelines, and actionable recommendations.